Global Information
회사소개 | 문의 | 위시리스트

세계의 티카그렐러 시장 예측

Global Ticagrelor Market Research Report Forecast to 2027

리서치사 Market Research Future
발행일 2019년 04월 상품 코드 841557
페이지 정보 영문 101 Pages
가격
US $ 4,450 ₩ 5,254,000 Unprintable PDF by E-mail (Single User License)
US $ 6,250 ₩ 7,380,000 Printable PDF by E-mail (Corporate User License)


세계의 티카그렐러 시장 예측 Global Ticagrelor Market Research Report Forecast to 2027
발행일 : 2019년 04월 페이지 정보 : 영문 101 Pages

세계의 티카그렐러(Ticagrelor) 시장에 대해 조사 분석했으며, 시장 개요, 시장 동향, 시장 성장 촉진요인/억제요인, 투약량별, 투여 경로별, 용도별, 최종사용자별, 지역별 시장 분석, 주요 기업 개요 등에 대해 정리했습니다.

제1장 보고서 서문

제2장 서론

제3장 조사 방법

제4장 시장 역학

  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제5장 시장 요인 분석

  • Porter's Five Forces 모델
  • 밸류체인 분석
  • 수급 격차 분석
  • 가격 분석
  • 투자 기회
  • 거시경제학적 지표
  • 파이프라인 분석

제6장 세계의 티카그렐러 시장 : 투약량별(mg)

  • 서론
  • 90mg
  • 60mg

제7장 세계의 티카그렐러 시장 : 투여 경로별

  • 서론
  • 경구
  • 경비 튜브

제8장 세계의 티카그렐러 시장 : 용도별

  • 서론
  • 급성 관상동맥 증후군
  • 심장 수술

제9장 세계의 티카그렐러 시장 : 최종사용자별

  • 서론
  • 병원/클리닉
  • 외래 진료소

제10장 세계의 티카그렐러 시장 : 지역별

  • 서론
  • 아메리카
  • 유럽
  • 아시아태평양
  • 세계의 기타 국가

제11장 경쟁 상황

제12장 기업 개요

  • AstraZeneca, PLC

제13장 부록

KSM 19.05.30

List of Tables

  • TABLE 1 PRIMARY INTERVIEWS
  • TABLE 2 PIPELINE PRODUCTS
  • TABLE 3 GLOBAL TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 4 GLOBAL TICAGRELOR MARKET FOR 90 MG, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 5 GLOBAL TICAGRELOR MARKET FOR 60 MG, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 6 GLOBAL TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 7 GLOBAL TICAGRELOR MARKET FOR ORAL, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 8 GLOBAL TICAGRELOR MARKET FOR NASOGASTRIC TUBE, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 9 GLOBAL TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 10 GLOBAL TICAGRELOR MARKET FOR ACUTE CORONARY SYNDROME, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 11 GLOBAL TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 12 GLOBAL TICAGRELOR MARKET FOR HEART SURGERIES, BY REGION 2015-2027 (USD MILLION)
  • TABLE 13 GLOBAL TICAGRELOR MARKET FOR ANGIOPLASTY, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 14 GLOBAL TICAGRELOR MARKET FOR STENT PLACEMENT, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 15 GLOBAL TICAGRELOR MARKET FOR CORONARY ARTERY BYPASS GRAFT-, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 16 GLOBAL TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 17 GLOBAL TICAGRELOR MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 18 GLOBAL TICAGRELOR MARKET FOR AMBULATORY CENTERS, BY REGION, 2015-2027 (USD MILLION)
  • TABLE 19 GLOBAL TICAGRELOR MARKET, BY REGION 2015-2027 (USD MILLION)
  • TABLE 20 AMERICAS TICAGRELOR MARKET, BY REGION 2015-2027 (USD MILLION)
  • TABLE 21 AMERICAS TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 22 AMERICAS TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 23 AMERICAS TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 24 AMERICAS TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 25 AMERICAS TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 26 NORTH AMERICA TICAGRELOR MARKET, BY COUNTRY 2015-2027 (USD MILLION)
  • TABLE 27 NORTH AMERICA TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 28 NORTH AMERICA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 29 NORTH AMERICA TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 30 NORTH AMERICA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 31 NORTH AMERICA TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 32 U.S. TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 33 U.S. TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 34 U.S. TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 35 U.S. TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 36 U.S. TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 37 CANADA TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 38 CANADA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 39 CANADA TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 40 CANADA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 41 CANADA TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 42 SOUTH AMERICA TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 43 SOUTH AMERICA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 44 SOUTH AMERICA TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 45 SOUTH AMERICA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 46 SOUTH AMERICA TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 47 EUROPE TICAGRELOR MARKET, BY REGION 2015-2027 (USD MILLION)
  • TABLE 48 EUROPE TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 49 EUROPE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 50 EUROPE TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 51 EUROPE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 52 EUROPE TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 53 WESTERN EUROPE TICAGRELOR MARKET, BY COUNTRY 2015-2027 (USD MILLION)
  • TABLE 54 WESTERN EUROPE TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 55 WESTERN EUROPE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 56 WESTERN EUROPE TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 57 WESTERN EUROPE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 58 WESTERN EUROPE TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 59 GERMANY TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 60 GERMANY TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 61 GERMANY TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 62 GERMANY TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 63 GERMANY TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 64 U.K. TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 65 U.K. TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 66 U.K. TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 67 U.K. TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 68 U.K. TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 69 FRANCE TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 70 FRANCE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 71 FRANCE TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 72 FRANCE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 73 FRANCE TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 74 ITALY TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 75 ITALY TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 76 ITALY TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 77 ITALY TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 78 ITALY TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 79 SPAIN TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 80 SPAIN TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 81 SPAIN TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 82 SPAIN TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 83 SPAIN TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 84 REST OF WESTERN EUROPE TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 85 REST OF WESTERN EUROPE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 86 REST OF WESTERN EUROPE TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 87 REST OF WESTERN EUROPE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 88 REST OF WESTERN EUROPE TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 89 EASTERN EUROPE TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 90 EASTERN EUROPE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 91 EASTERN EUROPE TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 92 EASTERN EUROPE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 93 EASTERN EUROPE TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 94 ASIA PACIFIC TICAGRELOR MARKET, BY COUNTRY 2015-2027 (USD MILLION)
  • TABLE 95 ASIA PACIFIC TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 96 ASIA PACIFIC TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 97 ASIA PACIFIC TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 98 ASIA PACIFIC TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 99 ASIA PACIFIC TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 100 JAPAN TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 101 JAPAN TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 102 JAPAN TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 103 JAPAN TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 104 JAPAN TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 105 CHINA TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 106 CHINA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 107 CHINA TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 108 CHINA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 109 CHINA TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 110 INDIA TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 111 INDIA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 112 INDIA TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 113 INDIA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 114 INDIA TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 115 AUSTRALIA TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 116 AUSTRALIA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 117 AUSTRALIA TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 118 AUSTRALIA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 119 AUSTRALIA TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 120 REPUBLIC OF KOREA TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 121 REPUBLIC OF KOREA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 122 REPUBLIC OF KOREA TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 123 REPUBLIC OF KOREA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 124 REPUBLIC OF KOREA TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 125 REST OF ASIA PACIFIC TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 126 REST OF ASIA PACIFIC TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 127 REST OF ASIA PACIFIC TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 128 REST OF ASIA PACIFIC TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 129 REST OF ASIA PACIFIC TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 130 REST OF THE WORLDTICAGRELOR MARKET, BY REGION 2015-2027 (USD MILLION)
  • TABLE 131 REST OF THE WORLDTICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 132 REST OF THE WORLDTICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 133 REST OF THE WORLDTICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 134 REST OF THE WORLDTICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 135 REST OF THE WORLDTICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 136 MIDDLE EAST TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 137 MIDDLE EAST TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 138 MIDDLE EAST TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 139 MIDDLE EAST TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 140 MIDDLE EAST TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 141 AFRICA TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 142 AFRICA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 143 AFRICA TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 144 AFRICA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 145 AFRICA TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)
  • TABLE 146 OTHER COUNTRIES TICAGRELOR MARKET, BY DOSAGE (MG) 2015-2027 (USD MILLION)
  • TABLE 147 OTHER COUNTRIES TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2015-2027 (USD MILLION)
  • TABLE 148 OTHER COUNTRIES TICAGRELOR MARKET, BY APPLICATION 2015-2027 (USD MILLION)
  • TABLE 149 OTHER COUNTRIES TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2015-2027 (USD MILLION)
  • TABLE 150 OTHER COUNTRIES TICAGRELOR MARKET, BY END-USER 2015-2027 (USD MILLION)

List of Figures

  • FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES
  • FIGURE 2 MARKET DYNAMICS: GLOBAL TICAGRELOR MARKET
  • FIGURE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL TICAGRELOR MARKET
  • FIGURE 4 VALUE CHAIN ANALYSIS OF THE GLOBAL TICAGRELOR MARKET
  • FIGURE 5 GLOBAL TICAGRELOR MARKET, BY DOSAGE (MG) 2017 & 2027 (USD MILLION)
  • FIGURE 6 GLOBAL TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2017 & 2027 (USD MILLION)
  • FIGURE 7 GLOBAL TICAGRELOR MARKET, BY APPLICATION 2017 & 2027 (USD MILLION)
  • FIGURE 8 GLOBAL TICAGRELOR MARKET, FOR HEART SURGERIES BY TYPE 2017 & 2027 (USD MILLION)
  • FIGURE 9 GLOBAL TICAGRELOR MARKET, BY END-USER 2017 & 2027 (USD MILLION)
  • FIGURE 10 GLOBAL TICAGRELOR MARKET, BY REGION 2017 & 2027 (USD MILLION)
  • FIGURE 11 AMERICAS TICAGRELOR MARKET SHARE, BY REGION 2017 (%)
  • FIGURE 12 AMERICAS TICAGRELOR MARKET SHARE, BY COUNTRY 2017 (%)
  • FIGURE 13 EUROPE TICAGRELOR MARKET, BY REGION 2017 (%)
  • FIGURE 14 WESTERN EUROPE TICAGRELOR MARKET, BY COUNTRY 2017 (%)
  • FIGURE 15 ASIA PACIFIC TICAGRELOR MARKET, BY COUNTRY 2017 (%)
  • FIGURE 16 REST OF THE WORLDTICAGRELOR MARKET, BY REGION 2017(%)

Ticagrelor Market Research Report: by Dosage (90 MG, 60 MG), by Route of Administration (Oral, Nasogastric Tube), by Application (Acute Coronary Syndrome, Heart Surgeries), by End-user (Hospitals & Clinics, Ambulatory Centers, Others), and Region - Global Forecast till 2027

Market analysis

Ticagrelor is a platelet total inhibitor which blocks the platelets from staying together and prevents blood clusters. It is a medication taken in combination with ibuprofen to forestall heart attacks or strokes in individuals with heart conditions, for example, intense coronary disorder. The developing quantities of the aging masses can likewise goad the market development. The older, who are prone to heart conditions, attributable to their age and low invulnerability levels can give a chance to the market. This is buttressed by the study by United Nations, in which the senior people over the age of 60 had achieved 962 million out of 2017. Be that as it may, the adverse impacts of the medication can be inconvenient to the ticagrelor market development. The global ticagrelor market is expected to reach the value of USD 2,554.39 million by the year 2027 by exhibiting a growth rate of 9% CAGR over the forecast period (2018-2027).

Market segmentation

The global ticagrelor market is segmented on the basis of its dosage, administration, applications, end-users and regional demand. Based on its dosage, the ticagrelor market is divided into two variants, namely 60 Mg and 90 Mg. On the basis of its administration, the market is sectioned into oral and nasogastric tube. Major applications in the ticagrelor market are acute coronary syndrome and heart surgeries. Major end-users of the global ticagrelor market include ambulatory centers,hospitals & clinics, and others.

Regional analysis

Geographically, the global ticagrelor market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

The global ticagrelor market can expand in size owing to the growing incidence of cardiovascular diseases. As per the recent reports by American Heart Association in the year 2014, nearly 31% of deaths in the U.S. were because of the cardiovascular disorders.

Table of Contents

1 Report Prologue

2 Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Research Objective
  • 2.4 Assumptions & Limitations
    • 2.4.1 Assumptions
    • 2.4.2 Limitations
    • 2.4.3 Market Structure

3 Research Methodology

  • 3.1 Primary Research Methodology
  • 3.2 Secondary Research Methodology
  • 3.3 Market Size Estimation
  • 3.4 Forecast Model

4 Market Dynamics

  • 4.1 Drivers
    • 4.1.1 Rising Cardiovascular Disorders
    • 4.1.2 Increasing Geriatric Population
  • 4.2 Restraints
    • 4.2.1 High Bleeding Complications
  • 4.3 Opportunities
    • 4.3.1 Exploring New Applications

5 Market Factor Analysis

  • 5.1 Porter's Five Forces Model
    • 5.1.1 Bargaining Power of Suppliers
    • 5.1.2 Bargaining Power of Buyers
    • 5.1.3 Threat of New Entrants
    • 5.1.4 Threat of Substitutes
    • 5.1.5 Intensity of Rivalry
  • 5.2 Value Chain Analysis
    • 5.2.1 R&D
    • 5.2.2 Manufacturing
    • 5.2.3 Distribution & Sales
    • 5.2.4 Post-Sales Monitoring
  • 5.3 Demand & Supply: Gap Analysis
  • 5.4 Pricing Analysis
  • 5.5 Investment Opportunities
  • 5.6 Macroeconomic Indicators
  • 5.7 Pipeline Analysis

6 The Global Ticagrelor Market, by Dosage (Mg)

  • 6.1 Introduction
  • 6.2 90 MG
  • 6.3 60 MG

7 The Global Ticagrelor Market, by Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Nasogastric Tube

8 The Global Ticagrelor Market, by Application

  • 8.1 Introduction
  • 8.2 Acute Coronary Syndrome
  • 8.3 Heart Surgeries
    • 8.3.1 Angioplasty
    • 8.3.2 Stent Placement
    • 8.3.3 Coronary Artery Bypass Graft

9 The Global Ticagrelor Market, by End-User

  • 9.1 Introduction
  • 9.2 Hospitals and Clinics
  • 9.3 Ambulatory Centers

10 The Global Ticagrelor Market, by Region

  • 10.1 Introduction
  • 10.2 Americas
    • 10.2.1 North America
      • 10.2.1.1 US
      • 10.2.1.2 Canada
    • 10.2.2 South America
  • 10.3 Europe
    • 10.3.1 Western Europe
      • 10.3.1.1 Germany
      • 10.3.1.2 U.K.
      • 10.3.1.3 France
      • 10.3.1.4 Italy
      • 10.3.1.5 Spain
      • 10.3.1.6 Rest of Western Europe
    • 10.3.2 Eastern Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 Republic of Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Rest of the World
    • 10.5.1 Middle East
    • 10.5.2 Africa
    • 10.5.3 Other Countries

11 Company Landscape

  • 11.1 Introduction

12 Company Profiles

  • 12.1 AstraZeneca, PLC
    • 12.1.1 Company Overview
    • 12.1.2 Financial Overview
    • 12.1.3 Products Offering
    • 12.1.4 Key Developments
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Strategy

13 Appendix

  • 13.1 Discussion Blue Print
  • 13.2 References
Back to Top
전화 문의
F A Q